CN103099843A - Health-care product capsule for treating cancers and preparation method thereof - Google Patents
Health-care product capsule for treating cancers and preparation method thereof Download PDFInfo
- Publication number
- CN103099843A CN103099843A CN2012105475258A CN201210547525A CN103099843A CN 103099843 A CN103099843 A CN 103099843A CN 2012105475258 A CN2012105475258 A CN 2012105475258A CN 201210547525 A CN201210547525 A CN 201210547525A CN 103099843 A CN103099843 A CN 103099843A
- Authority
- CN
- China
- Prior art keywords
- parts
- dichloromethane
- cancer
- capsule
- intermediate material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a health-care product capsule for treating cancers and a preparation method thereof. The product contains the following ingredients in parts by weight: 70 parts of taxus chinensis extract, 50 parts of liquorice, 16 parts of red ginseng, and 10 parts of enzyme microorganism. The pharmaceutical composition for treating cancers is a traditional Chinese medicine capsule. The capsule has the functions of strengthening the body resistance, eliminating evil, building, whitening, dispersing blood stasis, easing pain, improving hypoxia tolerant capability, stagnating cancer cell division, inducing cancer cell apoptosis, activating macrophage, and restoring the immune function on the cancel cell, and is used for treating cancers. The enzyme microorganism is added to the pharmaceutical composition disclosed by the invention, so that the absorption and utilization rate is enhanced and the microbiota of an intestinal tract of a sufferer is improved; the health-care product capsule is high in security, free of toxic or side effects, free of dependency, stable and controllable in quality, convenient to carry and take, simple in preparation process and can be prepared by common equipment.
Description
Technical field
The invention belongs to the health care medicine field, particularly relate to a kind of health product capsule that is used for the treatment of cancer and preparation method thereof.
Background technology
Cancer becomes the No.1 killer of human health just gradually, and the annual new tumour patient of China approximately 2,500,000 because the cancer mortality number is 1,400,000, namely just has 1 people to die from cancer in every dead 5 people.At first the control of cancer will rely on healthy lifestyles, regularly carry out screening for cancer, standardization diagnosis and treatment cancer.World Health Organization's latest data shows, before the year two thousand twenty, whole world cancer morbidity will increase by 50%, be to increase 1,500 ten thousand cancer patients every year newly, moreover, the death toll of cancer also rapidly rises in the whole world, the whole world in 2007 has 7,600,000 people and dies from cancer, the year two thousand thirty, this numeral may increase to 1,320 ten thousand, the new cancer patient in the whole world 20% is in China, 24% cancer mortality patient is in China, World Health Organization calls upon States to work out whole nation plan and the specific embodiments of anti-cancer, and lay special stress on is to cancer prevention, early detection and early treatment's significance, if take full advantage of global existing knowledge and technology, implementing as far as possible best means prevents cancer and treats, can save millions of every year, even nearly ten million cancer patient's life.From the situation of China, cancer is just becoming the No.1 killer of compatriots' health, and China's tumor is that not only mortality rate is obvious ascendant trend, and the characteristics that have developing country and developed country spectrum occurred frequently concurrently and deposit.
Summary of the invention
Purpose of the present invention aims to provide a kind of health product capsule that is used for the treatment of cancer and preparation method thereof, it is Chinese medicine combination, can overcome the shortcoming of existing market existing procucts, strengthen absorption rate, improve the Intestinal Mucosal Injury in Patients Undergoing microbiota, effective, safe, have no side effect, no dependence, stable and controllable for quality, be easy to carry and take, the simple advantage of preparation technology.
Technical scheme of the present invention is: a kind of health product capsule that is used for the treatment of cancer is provided, it is characterized in that crude drug composition and weight proportion thereof that it contains are 70 parts of Taxus extracts, 50 parts, Radix Glycyrrhizae, 16 parts of Radix Ginseng Rubra, 10 parts of enzymatic microorganism.
A kind of preparation method that is used for the treatment of the health product capsule of cancer is characterized in that it comprises the following steps:
step 1) is got leaf of Japanese Yew, branch, bark is pulverized, after crossing 20 mesh sieves, first make solvent with 95% ethanol of 5 times of raw material weights, flood after 48 hours, percolation slowly, the collection liquid of filtering, 40 ℃ of decompression recycling ethanols are the intermediate material A to doing, water and dichloromethane are fully mixed again by 5 times of weight and intermediate material A dissolving mix homogeneously to the intermediate material A by the 2:1 weight ratio, tell and collect dichloromethane solution after standing 4 hours after mix homogeneously, all the other mixed liquors are used dichloromethane extraction 3 times again, merge each time dichloromethane solution, filter, the reclaim under reduced pressure dichloromethane is to dried intermediate material B, ethyl acetate and methanol are pressed the mixing of 3:1 weight ratio, mixed solution dissolves mix homogeneously by 5 times to intermediate material B and intermediate material B, solution after mix homogeneously adds kieselguhr and mixes thoroughly, removal of solvent under reduced pressure, both packed in the percolation bucket, first use the normal hexane percolation, continue and use the dichloromethane percolation, collect the dichloromethane percolate, the reclaim under reduced pressure dichloromethane is to doing, residue dissolves with the ethyl acetate of 5 times of weight, according to column chromatography, take silica gel as absorbent, n-hexane: acetone 75:25 is eluant, eluting, collection contains the eluent of paclitaxel, decompression and solvent recovery is to the drying Taxus extracts of getting,
Step 2) by following weight ratio weighting raw materials: 70 parts of the Taxus extracts of said extracted, 50 parts, Radix Glycyrrhizae, 16 parts of Radix Ginseng Rubra, 10 parts of enzymatic microorganism;
Step 3) is got step 2) described in Radix Glycyrrhizae, the red ginseng powder of weight portion be broken into coarse powder, make solvent with 5 times of 70% ethanol to raw material, flood after 48 hours, slowly percolation, collect percolate, reclaim ethanol, be condensed into thick paste, make wetting agent with 95% ethanol, fully mixing, granulation, dry below 60 ℃;
4) above-mentioned Radix Glycyrrhizae, Radix Ginseng Rubra fine powder are crossed 24 mesh sieves with Taxus extracts, enzymatic microorganism fine powder and evenly mix, upper capsule filling machine carries out filling, gets final product;
5) inner packing;
6) outer package, product inspection, warehouse-in.
Advantage of the present invention is: it is white that the pure Chinese medicine combination capsule in the present invention has righting, eliminating evil, potentiation, liter, blood stasis dispelling, analgesia, resisting oxygen lack stagnate the cancerous cell division, cancer cell specific induction of apoptosis, activating macrophage recovers the cancerous cell immunologic function.Can significantly increase biomembranous mobility, reduce LPO and pile up, activity that simultaneously can enhancement of SOD has the effect of antioxidant radical, can effectively anti-aging, anti-damage.
The present invention has paclitaxel, paclitaxel is the best natural drugs of middle and terminal cancer such as treatment Metastatic carcinoma in the ovary and breast carcinoma, pulmonary carcinoma, cervical cancer, rectal cancer, liver neoplasm, head tumor, leukemia, simultaneously pulmonary carcinoma, esophageal carcinoma also there is significant curative effect, paclitaxel also is used for the treatment of pernicious incidence scale cancer and other malignant tumor, paclitaxel has obvious inhibitory action to nephritis and parvovirus inflammation, tumour inhibiting rate can reach more than 60%, and also there is certain curative effect the aspects such as treatment psoriasis, rheumatic arthritis, Alzheimer and cardiovascular and cerebrovascular disease.a kind of health product capsule that is used for the treatment of cancer is that the medication that has definite curative effect in present Traditional Chinese Drug Anticancer Comprehensive Treatment is selected, to pulmonary carcinoma, gastric cancer, hepatocarcinoma, the intestinal cancer, esophageal carcinoma, breast carcinoma, cerebroma, nasopharyngeal carcinoma, the kinds of tumors curative effects such as bladder cancer are outstanding, dwindling the tumor body divides remission rate to reach 68.31%, by suppressing microtubule depolymerization, thereby reach the effect that suppresses tumor, a kind of health product capsule that is used for the treatment of cancer has the therapeutic effect that chemotherapy is equal to, pass through simultaneously compound compatibility, without chemotherapy side effect, pulmonary carcinoma and breast carcinoma, the chemotherapy replacement therapy medicine of the gynecological tumors such as cervical cancer.
Chinese medicine composition of the present invention is added enzymatic microorganism, strengthens absorption rate, improves the Intestinal Mucosal Injury in Patients Undergoing microbiota, strengthens health reparation, regeneration, self-healing function; Radix Ginseng Rubra has the energy strongly invigorating primordial QI, and multiple arteries and veins takes off admittedly, nourishing qi to stop; The Radix Glycyrrhizae invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription, the carbuncle sore tumefacting virus of dispelling, cushion toxicity, strong.
That Chinese medicine composition of the present invention has is safe, absorption rate is strong, have no side effect, no dependence, stable and controllable for quality, be easy to carry and take, the advantage such as preparation technology is simple.
The specific embodiment
The invention will be further described below in conjunction with specific embodiment, but not as limitation of the present invention.The part that is not described in detail in the present embodiment is to adopt prior art and industry standard or known approaches.
Embodiment
The crude drug composition that a kind of health product capsule that is used for the treatment of cancer contains and weight proportion thereof are 70 parts of Taxus extracts, 50 parts, Radix Glycyrrhizae, 16 parts of Radix Ginseng Rubra, 10 parts of enzymatic microorganism.
The preparation method that is used for the treatment of the health product capsule of cancer comprises the following steps:
step 1) is got leaf of Japanese Yew, branch, bark is pulverized, after crossing 20 mesh sieves, first make solvent with 95% ethanol of 5 times of raw material weights, flood after 48 hours, percolation slowly, the collection liquid of filtering, 40 ℃ of decompression recycling ethanols are the intermediate material A to doing, water and dichloromethane are fully mixed again by 5 times of weight and intermediate material A dissolving mix homogeneously to the intermediate material A by the 2:1 weight ratio, tell and collect dichloromethane solution after standing 4 hours after mix homogeneously, all the other mixed liquors are used dichloromethane extraction 3 times again, merge each time dichloromethane solution, filter, the reclaim under reduced pressure dichloromethane is to dried intermediate material B, ethyl acetate and methanol are pressed the mixing of 3:1 weight ratio, mixed solution dissolves mix homogeneously by 5 times to intermediate material B and intermediate material B, solution after mix homogeneously adds kieselguhr and mixes thoroughly, removal of solvent under reduced pressure, both packed in the percolation bucket, first use the normal hexane percolation, continue and use the dichloromethane percolation, collect the dichloromethane percolate, the reclaim under reduced pressure dichloromethane is to doing, residue dissolves with the ethyl acetate of 5 times of weight, according to column chromatography, take silica gel as absorbent, n-hexane: acetone 75:25 is eluant, eluting, collection contains the eluent of paclitaxel, decompression and solvent recovery is to the drying Taxus extracts of getting,
Step 2) by following weight ratio weighting raw materials: 70 parts of the Taxus extracts of said extracted, 50 parts, Radix Glycyrrhizae, 16 parts of Radix Ginseng Rubra, 10 parts of enzymatic microorganism;
Step 3) is got step 2) described in Radix Glycyrrhizae, the red ginseng powder of weight portion be broken into coarse powder, make solvent with 5 times of 70% ethanol to raw material, flood after 48 hours, slowly percolation, collect percolate, reclaim ethanol, be condensed into thick paste, make wetting agent with 95% ethanol, fully mixing, granulation, dry below 60 ℃;
4) above-mentioned Radix Glycyrrhizae, Radix Ginseng Rubra fine powder are crossed 24 mesh sieves with Taxus extracts, enzymatic microorganism fine powder and evenly mix, upper capsule filling machine carries out filling, gets final product;
5) inner packing;
6) outer package, product inspection, warehouse-in.
Above-mentioned percent is mass percent concentration, described n-hexane: acetone 75:25 is mass ratio.
The below is a kind of clinical observation that is used for the treatment of the health product capsule treatment cancer of cancer of the embodiment of the present invention:
1 data and method
1.1 physical data
Cancer patient's 200 examples that selection is received treatment voluntarily, male 103 examples, female's 97 examples, 37～78 years old age, year mean age (51.7 ± 16.2), the course of disease (6.6 ± 1.5) year, be divided at random treatment group 1, treatment group 2, treatment group 3, matched group, every group of 50 examples; Each is organized the patient age symptom and consists of without significant difference.Has comparability (P〉0.05).
1.2 Therapeutic Method
The treatment group Primary Care is consistent, and matched group is not taken medicine.Treatment group 1 is used the embodiment of the present invention, every day three times, one time 2,21 is a course for the treatment of.Treatment group 2 is used FUFANG BANMAO JIAONANG, the Yellow River, Shanxi Chinese medicine company limited, 1 time 3,2 times on the 1st; Treatment group 3 is used FUFANG TIANXIAN JIAONANG, Baishan Pharmaceutical Co., Ltd, Tonghua City, Jilin Prov., a 2-3 grain, 3 times on the one.
2 results
2.1 curative effect determinate standard
Clinical recent healing: symptom and sign and every inspection make moderate progress, alleviate, and focus is dwindled or disappeared, nothing recurrence in 4 years.It is normal that every inspection recovers substantially.Produce effects: symptom and sign and every inspection obviously improve, and focus is dwindled or disappeared in 4 years without recurrence; Effectively: symptom and sign and every inspection make moderate progress, alleviate, and focus is dwindled or disappeared; Invalid: without improving or worsening.
2.2 therapeutic outcome
| ? | Cure | Produce effects | Effectively | Invalid | Effective percentage |
| Contrast | ? | ? | ? | 50 | 0 |
| Treatment group 1 | 16 | 14 | 4 | 16 | 68% |
| Treatment group 2 | 10 | 6 | 6 | 28 | 44% |
| Treatment group 3 | 10 | 7 | 4 | 29 | 42% |
Case 1: clinical data: 1 routine colorectal cancer patients Zhang, at 52 years old age, cardinal symptom: abdominal distention, dyspepsia has poisoning symptom, is diagnosed as the mass-type colon cancer through hospital.
Therapeutic Method: adopt medicine of the present invention, every day three times, one time 2,21 is a course for the treatment of, treats 5 courses for the treatment of.Transference cure reduces through removing hospital's check lump, continues again to take medicine 2 courses for the treatment of, and hospital's check lump disappears.
Case 2: clinical data: 1 routine patients with gastric cancer temperature, 42 years old age, cardinal symptom: sometimes with belch, return acid, vomiting, splanchnoscopy has polyp of stomach, biopsy to differentiate as pernicious.
Therapeutic Method: adopt medicine of the present invention, every day three times, one time 2,21 is a course for the treatment of, treats 6 courses for the treatment of.Belch, return the sx↓s such as acid, vomiting, reduce through removing hospital's polyp of stomach.
3 discuss
Cancer is one of disease of contemporary prestige association human health, and mortality rate is high, and cure rate is low, and prevention and treatment cancer reduce its sickness rate and extensively received people's concern.Industrialized progress, the pollution of environment is day by day serious, and cancer morbidity increases.People's rhythm of life is also more and more nervous, and dietary structure significantly changes, and unsound diet increases, and causes cancer morbidity to increase, bad living habit, smoking and the easy cause cancer of excessive drinking.Chinese medicine thinks in the process that Cancerous disease forms, and is white by righting, eliminating evil, potentiation, liter, blood stasis dispelling, analgesia, raising hypoxia-bearing capability, the cancerous cell division is stagnated, cancer cell specific induction of apoptosis, activating macrophage, recovery to the cancerous cell immunologic function, is treatment cancer fundamentum.
Adopt natural Chinese medicine to import administration, white in line with righting, eliminating evil, potentiation, liter, the method for blood stasis dispelling, analgesia, raising hypoxia-bearing capability reaches and improves the quality of living to effect a permanent cure, and therapy rehabilitation, cures purpose.And then illustrate that in this invention, the affiliated prescription of embodiment is reliably effective.
Technique, pharmaceutical test method and production technology standard that the present invention does not have to describe in detail belong to existing technique, existing pharmaceutical test method and production technology standard, belong to the common practise not narration one by one here of the industry.
Claims (2)
1. a health product capsule that is used for the treatment of cancer, is characterized in that crude drug composition and weight proportion thereof that it contains are 70 parts of Taxus extracts, 50 parts, Radix Glycyrrhizae, 16 parts of Radix Ginseng Rubra, 10 parts of enzymatic microorganism.
2. preparation method that is used for the treatment of the health product capsule of cancer is characterized in that it comprises the following steps:
step 1) is got leaf of Japanese Yew, branch, bark is pulverized, after crossing 20 mesh sieves, first make solvent with 95% ethanol of 5 times of raw material weights, flood after 48 hours, percolation slowly, the collection liquid of filtering, 40 ℃ of decompression recycling ethanols are the intermediate material A to doing, water and dichloromethane are fully mixed again by 5 times of weight and intermediate material A dissolving mix homogeneously to the intermediate material A by the 2:1 weight ratio, tell and collect dichloromethane solution after standing 4 hours after mix homogeneously, all the other mixed liquors are used dichloromethane extraction 3 times again, merge each time dichloromethane solution, filter, the reclaim under reduced pressure dichloromethane is to dried intermediate material B, ethyl acetate and methanol are pressed the mixing of 3:1 weight ratio, mixed solution dissolves mix homogeneously by 5 times to intermediate material B and intermediate material B, solution after mix homogeneously adds kieselguhr and mixes thoroughly, removal of solvent under reduced pressure, both packed in the percolation bucket, first use the normal hexane percolation, continue and use the dichloromethane percolation, collect the dichloromethane percolate, the reclaim under reduced pressure dichloromethane is to doing, residue dissolves with the ethyl acetate of 5 times of weight, according to column chromatography, take silica gel as absorbent, n-hexane: acetone 75:25 is eluant, eluting, collection contains the eluent of paclitaxel, decompression and solvent recovery is to the drying Taxus extracts of getting,
Step 2) by following weight ratio weighting raw materials: 70 parts of the Taxus extracts of said extracted, 50 parts, Radix Glycyrrhizae, 16 parts of Radix Ginseng Rubra, 10 parts of enzymatic microorganism;
Step 3) is got step 2) described in Radix Glycyrrhizae, the red ginseng powder of weight portion be broken into coarse powder, make solvent with 5 times of 70% ethanol to raw material, flood after 48 hours, slowly percolation, collect percolate, reclaim ethanol, be condensed into thick paste, make wetting agent with 95% ethanol, fully mixing, granulation, dry below 60 ℃;
4) above-mentioned Radix Glycyrrhizae, Radix Ginseng Rubra fine powder are crossed 24 mesh sieves with Taxus extracts, enzymatic microorganism fine powder and evenly mix, upper capsule filling machine carries out filling, gets final product;
5) inner packing;
6) outer package, product inspection, warehouse-in.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105475258A CN103099843A (en) | 2012-12-17 | 2012-12-17 | Health-care product capsule for treating cancers and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105475258A CN103099843A (en) | 2012-12-17 | 2012-12-17 | Health-care product capsule for treating cancers and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103099843A true CN103099843A (en) | 2013-05-15 |
Family
ID=48308255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105475258A Pending CN103099843A (en) | 2012-12-17 | 2012-12-17 | Health-care product capsule for treating cancers and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103099843A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1733062A (en) * | 2005-09-02 | 2006-02-15 | 北京正大绿洲医药科技有限公司 | Compound yew drop pills and its preparation method |
| CN1739601A (en) * | 2005-09-08 | 2006-03-01 | 王衡新 | Anticancer Chinese medicine prepn and its prepn process |
| CN1813869A (en) * | 2005-11-30 | 2006-08-09 | 重庆安格禾顺科贸有限公司 | Medicine for antitumor and regulating body immunological competence and its preparing method |
| CN1813870A (en) * | 2005-11-30 | 2006-08-09 | 重庆安格禾顺科贸有限公司 | Medicinal composition for antitumor and regulating body immunological competence and its preparing method |
| CN101342298A (en) * | 2008-01-08 | 2009-01-14 | 邝德明 | Vegetable enzyme soup formulation |
| CN102641308A (en) * | 2012-05-16 | 2012-08-22 | 江苏红豆杉生物科技有限公司 | Taxus chinensis var mairei Chinese herbal material as well as processing method and application thereof |
| CN102755600A (en) * | 2012-08-03 | 2012-10-31 | 南京中医药大学 | Traditional Chinese medicine compound for resisting breast cancer metastasis and reoccurrence |
-
2012
- 2012-12-17 CN CN2012105475258A patent/CN103099843A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1733062A (en) * | 2005-09-02 | 2006-02-15 | 北京正大绿洲医药科技有限公司 | Compound yew drop pills and its preparation method |
| CN1739601A (en) * | 2005-09-08 | 2006-03-01 | 王衡新 | Anticancer Chinese medicine prepn and its prepn process |
| CN1813869A (en) * | 2005-11-30 | 2006-08-09 | 重庆安格禾顺科贸有限公司 | Medicine for antitumor and regulating body immunological competence and its preparing method |
| CN1813870A (en) * | 2005-11-30 | 2006-08-09 | 重庆安格禾顺科贸有限公司 | Medicinal composition for antitumor and regulating body immunological competence and its preparing method |
| CN101342298A (en) * | 2008-01-08 | 2009-01-14 | 邝德明 | Vegetable enzyme soup formulation |
| CN102641308A (en) * | 2012-05-16 | 2012-08-22 | 江苏红豆杉生物科技有限公司 | Taxus chinensis var mairei Chinese herbal material as well as processing method and application thereof |
| CN102755600A (en) * | 2012-08-03 | 2012-10-31 | 南京中医药大学 | Traditional Chinese medicine compound for resisting breast cancer metastasis and reoccurrence |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100428949C (en) | Anticancer taxad Chinese medicine prepn | |
| CN103768398B (en) | Traditional Chinese medicine composition for treating advanced lung tumors | |
| CN103191194A (en) | Traditional chinese medicine extract and preparation method thereof | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN101716318B (en) | Traditional Chinese medicine preparation for treating tumor of digestive system | |
| CN104352608A (en) | Traditional Chinese medicine capable of benefiting qi, activating blood circulation, softening hardness, dissipating stagnation, realizing detoxification and relieving pain as well as preparation method thereof | |
| CN101502579A (en) | Chinese medicinal composition for treating digestive tumor and preparation method thereof | |
| CN108434399B (en) | Traditional Chinese medicine composition for enhancing sensitivity of breast cancer chemotherapy and preparation method thereof | |
| CN108186794B (en) | Traditional Chinese medicine composition for treating lung cancer and preparation method and application thereof | |
| CN101485841B (en) | Health-care granule containing astragalus and coix seed | |
| CN103550718B (en) | A kind of Chinese medicine composition for the treatment of pulmonary carcinoma | |
| CN103099843A (en) | Health-care product capsule for treating cancers and preparation method thereof | |
| CN1931336B (en) | Chinese medicine composition and its preparation process | |
| CN101590209B (en) | Medicament for treating tumors and preparation method thereof | |
| CN1943607B (en) | Chinese medicine composition for nourishing qi and yin and its preparing method | |
| CN103142934A (en) | Traditional Chinese medicinal composition for treating lung cancer and liver cancer | |
| CN104825817A (en) | Traditional Chinese medicine preparation with antitumor effect | |
| CN101301456A (en) | Compound glaucescent fissistigma root capsule | |
| CN103230456A (en) | Traditional Chinese medicine extract and preparation method thereof | |
| CN103751706A (en) | Anti-cancer traditional Chinese medicine composition and application thereof | |
| CN103251771A (en) | Traditional chinese medicine composition | |
| CN100348249C (en) | Method for preparing medicine for treating malignancy disease and use thereof | |
| CN102949667A (en) | Health-care product tablet for treating gastritis and preparation method thereof | |
| CN103417906A (en) | Applications of compound mylabris traditional Chinese medicine composition and preparations thereof in preparing drugs for curing depression | |
| CN102631396B (en) | Anti-lung cancer alstonia-leaf traditional Chinese herbal composite, method for preparing same and application thereof in preparing anti-lung cancer medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130515 |